We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products

News   Jun 07, 2017 | Original Story from Medherant

 
Medherant Appoints Sheryl Caswell to Lead Clinical Development of Products
 
 
 

RELATED ARTICLES

Novel Drug Targets Advanced Kidney Cancer

News

Scientists have reported promising activity of a novel drug called MK-6482, that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease. The study authors concluded that the drug was well-tolerated with a favorable safety profile.

READ MORE

Protein Drug Grown in the Leaves of Lettuces To Treat Pulmonary Arterial Hypertension

News

A team of scientists has produced a protein drug in lettuce leaves to treat pulmonary arterial hypertension – a rare but deadly condition that causes the heart to work extra hard to pump blood to the lungs and around the rest of the body.

READ MORE

Side-stepping Side Effects With State-of-the-Art Radiotherapy

News

A major clinical trial has shown that changing the way radiotherapy is delivered could significantly reduce the side effects linked to the treatment, for prostate cancer.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE